ChromaCode Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $38M
Latest Deal Amount
  • Investors
  • 8

ChromaCode General Information

Description

Developer of molecular diagnostics technology designed to focus on bioinformatics and pedigree. The company's technology leverages patented mathematical methods and algorithmic enhancements to enrich signal processing from the most popular life science instrumentation by producing unique signal patterns for each combination of targets, enabling healthcare industry and laboratory customers to improve the capabilities of biochemical assays at lower costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
  • 2330 Faraday Avenue
  • Suite 100
  • Carlsbad, CA 92011
  • United States
+1 (442) 000-0000

ChromaCode Timeline

2017201820192020
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ChromaCode Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 19-May-2020 $38M 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 25-Apr-2017 0000 000.00 0000 Completed Generating Revenue
1. Early Stage VC (Series A1) 13-Aug-2015 $2.2M $2.2M 00.00 Completed Generating Revenue
To view ChromaCode’s complete valuation and funding history, request access »

ChromaCode Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A1 10,805,082 $0.000100 $0.02 $0.24 $0.24 1x $0.24 9.13%
To view ChromaCode’s complete cap table history, request access »

ChromaCode Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular diagnostics technology designed to focus on bioinformatics and pedigree. The company's technology
Biotechnology
Carlsbad, CA
000.00
000 0000-00-00
00000000000 000.00

0000000

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepte
0000000000 000000000
South San Francisco, CA
00 As of 0000
00.000
000000&0 00.000

00000 00

nim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
0000000000 000000000
Malvern, PA
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ChromaCode Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Linkage Biosciences Formerly VC-backed South San Francisco, CA 00 00.000 000000&0 00.000
00000 0000000 Venture Capital-Backed Malvern, PA 00 000.00 000000000 - 000.00
000000000 Venture Capital-Backed San Francisco, CA 00 000.00 000000000 - 000.00
0000000000 Formerly VC-backed Beverly, MA 00 00.000 000000&0 00.000
0000000 Accelerator/Incubator Backed Cambridge, MA 000000000000
You’re viewing 5 of 12 competitors. Get the full list »

ChromaCode Executive Team (8)

Name Title Board Seat Contact Info
Gregory Gosch Co-Founder, Chief Executive Officer, President and Board Member
Aditya Rajagopal Ph.D Co-Founder, Chief Technology Officer & Board Member
Darin Leigh Chief Commercialization Officer
Brett Brown Vice President, Finance and Administration
Karen Menge Ph.D Vice President of Research & Development
You’re viewing 5 of 8 executive team members. Get the full list »

ChromaCode Board Members (9)

Name Representing Role Since
Aditya Rajagopal Ph.D ChromaCode Co-Founder, Chief Technology Officer & Board Member 000 0000
Alexander Dickinson Ph.D ChromaCode Co-Founder, Executive Chairman and Board Member 000 0000
Carol Gallagher New Enterprise Associates Board Member 000 0000
James Blair Ph.D Domain Associates Board Member 000 0000
Jenny Yip Adjuvant Capital Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

ChromaCode Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adjuvant Capital Impact Investing Minority 000 0000 000000 0
California Institute of Technology Endowment Limited Partner Minority 000 0000 000000 0
Moore Venture Partners Venture Capital Minority 000 0000 000000 0
Northpond Ventures Venture Capital Minority 000 0000 000000 0
Windham Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »